Mark For: CELTEGRIS™ trademark registration is intended to cover the categories of pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back injuries and joint injuries, skin wound and soft tissue wounds. [all]
Status
2022-08-22 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
David M. Kelly
Attorney Docket Number
6832.0035
Law Office Assigned
L50
Employee Name
PIGNATELLO, ELIZABETH
Timeline
2001-07-10
Application Filed
2002-09-24
Published
2002-09-24
Published for Opposition
2003-06-18
Abandon
2003-06-18
Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
DAVID M. KELLY FINNEGAN, HENDERSON, FARABOW, ET AL 1300 I ST NW FL 6-8 WASHINGTON DC 20005-3315
Good, Services, and Codes
(ABANDONED) IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back injuries and joint injuries, skin wound and soft tissue wounds
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back injuries and joint injuries, skin wound and soft tissue wounds
Trademark Filing History
Description
Date
Proceeding Number
ABANDONMENT - NO USE STATEMENT FILED
2003-09-11
NOA MAILED - SOU REQUIRED FROM APPLICANT
2002-12-17
PUBLISHED FOR OPPOSITION
2002-09-24
NOTICE OF PUBLICATION
2002-09-04
APPROVED FOR PUB - PRINCIPAL REGISTER
2002-06-26
EXAMINERS AMENDMENT MAILED
2002-06-24
PREVIOUS ALLOWANCE COUNT WITHDRAWN
2002-06-20
APPROVED FOR PUB - PRINCIPAL REGISTER
2002-06-18
CORRESPONDENCE RECEIVED IN LAW OFFICE
2002-02-20
NON-FINAL ACTION MAILED
2001-08-29
ASSIGNED TO EXAMINER
2001-08-25
77763
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.